Cargando…

Early and High SARS-CoV-2 Neutralizing Antibodies Are Associated with Severity in COVID-19 Patients from India

Patients with SARS-CoV-2 infection have a wide spectrum of clinical presentations, from asymptomatic infection, to mild illness, to severe disease with recovery or fatal outcome. Immune correlates of protection are not yet clear. To understand the association between presence and titers of neutraliz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shrivastava, Shubham, Palkar, Sonali, Shah, Jignesh, Rane, Prajakta, Lalwani, Sanjay, Mishra, Akhilesh Chandra, Arankalle, Vidya A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437163/ https://www.ncbi.nlm.nih.gov/pubmed/34138748 http://dx.doi.org/10.4269/ajtmh.21-0014

Ejemplares similares

Performance assessment of SARS-CoV-2 IgM & IgG ELISAs in comparison with plaque reduction neutralization test
por: Kulkarni, Ruta, et al.
Publicado: (2021)

Isolation and genetic characterization of SARS-CoV-2 from Indian patients in a single family without H/O travel abroad
por: Shrivastava, Shubham, et al.
Publicado: (2021)

Disease‐duration based comparison of subsets of immune cells in SARS CoV‐2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity
por: Kulkarni‐Munje, Archana, et al.
Publicado: (2021)

Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA
por: Kulkarni, Ruta, et al.
Publicado: (2021)

Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital
por: Arankalle, Vidya, et al.
Publicado: (2022)

Perinatal transmission of SARS-CoV-2 and transfer of maternal IgG/neutralizing anti-SARS-CoV-2 antibodies from mothers with asymptomatic infection during pregnancy
por: Malshe, Nandini, et al.
Publicado: (2021)

Immune Response of Indian Preterm Infants to Pentavalent Vaccine Varies With Component Antigens and Gestational Age
por: Kulkarni-Munje, Archana, et al.
Publicado: (2021)

Variable neutralizing antibody responses to 10 SARS-CoV-2 variants in natural infection with wild- type (B.1) virus, Kappa (B.1.617.1), and Delta (B.1.617.2) variants and COVISHIELD vaccine immunization in India: utility of the MSD platform
por: Patil, Rajashree, et al.
Publicado: (2023)

Elevated Levels of Neutrophil Activated Proteins, Alpha-Defensins (DEFA1), Calprotectin (S100A8/A9) and Myeloperoxidase (MPO) Are Associated With Disease Severity in COVID-19 Patients
por: Shrivastava, Shubham, et al.
Publicado: (2021)

Co-circulation of all the four dengue virus serotypes and detection of a novel clade of DENV-4 (genotype I) virus in Pune, India during 2016 season
por: Shrivastava, Shubham, et al.
Publicado: (2018)

Emergence of two distinct variants of SARS-CoV-2 and an explosive second wave of COVID-19: the experience of a tertiary care hospital in Pune, India
por: Shrivastava, Shubham, et al.
Publicado: (2022)

SARS-CoV-2 breakthrough infections during the second wave of COVID-19 at Pune, India
por: Doke, Prakash P., et al.
Publicado: (2023)

Time dependent decline of neutralizing antibody titers in COVID-19 patients from Pune, India and evidence of reinfection
por: Doke, Purwa, et al.
Publicado: (2022)

Stratified sero-prevalence revealed overall high disease burden of dengue but suboptimal immunity in younger age groups in Pune, India
por: Mishra, Akhilesh C., et al.
Publicado: (2018)

G, N, and P Gene-based Analysis of Chandipura Viruses, India
por: Avinash, Arankalle Vidya, et al.
Publicado: (2005)

Comparative assessment of commercial enzyme-linked immunosorbent assay & rapid diagnostic tests used for dengue diagnosis in India
por: Kulkarni, Ruta, et al.
Publicado: (2020)

Development and evaluation of a real-time one step Reverse-Transcriptase PCR for quantitation of Chandipura Virus
por: Kumar, Satyendra, et al.
Publicado: (2008)

Reported incidence and risk factors of childhood pneumonia in India: a community-based cross-sectional study
por: Gothankar, Jayashree, et al.
Publicado: (2018)

Enhanced humoral response in pregnant mice immunized with liposome encapsulated recombinant neutralizing epitope protein of Hepatitis- E virus
por: Joshi, Shivali Shirish, et al.
Publicado: (2015)

Chikungunya Outbreaks Caused by African Genotype, India
por: Yergolkar, Prasanna N., et al.
Publicado: (2006)

Prevalence and determinants of undernutrition among under-five children residing in urban slums and rural area, Maharashtra, India: a community-based cross-sectional study
por: Murarkar, Sujata, et al.
Publicado: (2020)

Prevalence of the Acute Respiratory Infections and Associated Factors in the Rural Areas and Urban Slum Areas of Western Maharashtra, India: A Community-Based Cross-Sectional Study
por: Murarkar, Sujata, et al.
Publicado: (2021)

Antibody-mediated neutralization of SARS-CoV-2
por: Gruell, Henning, et al.
Publicado: (2022)

Neutralizing antibodies for SARS-CoV-2 infection
por: Berenguer, Juan
Publicado: (2022)

Genomic Characterization of Nipah Virus, West Bengal, India
por: Arankalle, Vidya A., et al.
Publicado: (2011)

Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma
por: Mishra, Nitesh, et al.
Publicado: (2021)

Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies
por: Tada, Takuya, et al.
Publicado: (2022)

SARS-CoV-2 neutralizing antibody development strategies
por: BALCIOĞLU, Bertan Koray, et al.
Publicado: (2020)

Human antibodies can neutralize SARS-CoV-2
por: Catalan-Dibene, Jovani
Publicado: (2020)

Neutralizing antibody titres in SARS-CoV-2 infections
por: Lau, Eric H. Y., et al.
Publicado: (2021)

Neutralizing and enhancing antibodies against SARS-CoV-2
por: Liu, Yafei, et al.
Publicado: (2022)

Stability of SARS-CoV-2 RNA in Viral Lysis Buffer Stored at Different Temperatures
por: Perumal, Nagaraj, et al.
Publicado: (2020)

Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers
por: Vanshylla, Kanika, et al.
Publicado: (2022)

Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody
por: Liu, Kuan-Ting, et al.
Publicado: (2022)

Neutralizing antibody responses to SARS-CoV-2: A population based seroepidemiological analysis
por: Sharma, Pragya, et al.
Publicado: (2022)

Antibody-like proteins that capture and neutralize SARS-CoV-2
por: Kondo, T., et al.
Publicado: (2020)

Perspectives on the development of neutralizing antibodies against SARS-CoV-2
por: Ho, Mitchell
Publicado: (2020)

Neutralizing antibodies targeting SARS-CoV-2 spike protein
por: Xiaojie, Shi, et al.
Publicado: (2021)

Epitope Analysis of Anti-SARS-CoV-2 Neutralizing Antibodies
por: Xue, Jun-biao, et al.
Publicado: (2021)

Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers
por: Rujas, Edurne, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vo0tbrsgrpd7fgm2ojtsj4a3l5